Sermorelin 10mg — Vial Spec, Reconstitution Math & COA

Overview of Sermorelin 10mg as a Research Compound

Sermorelin acetate is a synthetic 29-amino-acid peptide representing the N-terminal sequence (1-29) of endogenous growth hormone-releasing hormone (GHRH). In laboratory settings, this truncated peptide fragment retains full receptor-binding affinity for the GHRH receptor (GHRH-R) on pituitary somatotrophs, serving as a primary tool for evaluating receptor kinetics, adenylate cyclase activation, and downstream somatotroph signaling pathways. When sourcing reagents across our catalog of all peptides, investigators frequently evaluate specific mass options to balance workflow demands against reagent stability.

The 10mg specification provides a concentrated solid cake intended for high-density assays or multi-subject animal model series. While PX1 Research stocks core formats such as the standard Sermorelin product line, larger 10mg vial allocations are engineered for specialized laboratory setups where consistent stock solutions are needed across repeated experimental blocks. All material supplied is strictly designated as a research compound for laboratory research use only, and is explicitly not intended for clinical, therapeutic, or human diagnostic applications.

Preclinical investigations utilize Sermorelin to investigate the pulsatile secretion of growth hormone without relying on full-length GHRH(1-44). The shortened amino acid chain offers superior peptide synthesis yield, enhanced solubility profile in aqueous buffers, and defined enzymatic degradation pathways in vitro, making it an essential baseline secretagogue in cellular signaling research.

Vial Architecture and Lyophilization Metrics

Each 10mg vial of Sermorelin is manufactured using precision lyophilization cycles within GMP-compliant facilities. The lyophilization cake consists of pure Sermorelin acetate co-lyophilized with an inert bulking agent (typically mannitol) to optimize cake structure, facilitate rapid reconstitution, and maintain molecular stability during long-term storage.

Prior to sealing under an inert nitrogen vacuum, the moisture content is measured via Karl Fischer titration to guarantee residual moisture levels below 2.0%. High residual water content can induce slow peptide hydrolysis and peptide aggregation over time; thus, stringent desiccated stopper sealing is enforced. PX1 vials utilize high-grade USP Type I borosilicate glass paired with chlorobutyl rubber stoppers and aluminum flip-off seals to prevent atmospheric contamination and moisture entry.

For long-term storage prior to reconstitution, solid lyophilized vials should be maintained at -20°C in a desiccated environment. Under these conditions, the peptide matrix maintains high structural integrity, resisting oxidation at the methionine-27 residue and minimizing deamidation at sensitive asparagine positions.

Step-by-Step Reconstitution Math for 10mg Vials

Reconstituting a 10mg peptide mass requires careful volume calculation to ensure target working concentrations are achieved accurately without exceeding stock solution stability limits. Researchers typically employ Bacteriostatic Water (0.9% benzyl alcohol) or sterile PBS depending on the downstream assay requirements.

To achieve specific working concentrations from a 10mg (10,000 mcg) solid cake, calculate the resulting concentration based on the diluent volume added:

• 1.0 mL Diluent Volume: Adding 1.0 mL of reconstituting fluid yields a stock concentration of 10.0 mg/mL (10,000 mcg/mL or 10 mcg/µL). This high-density stock is ideal for creating secondary aliquots or concentrated micro-dosing protocols in low-volume microplates. • 2.0 mL Diluent Volume: Adding 2.0 mL yields a stock concentration of 5.0 mg/mL (5,000 mcg/mL or 5 mcg/µL). This concentration offers an optimal balance between volumetric measuring precision and liquid handling handling parameters. • 3.0 mL Diluent Volume: Adding 3.0 mL yields a stock concentration of 3.33 mg/mL (3,333 mcg/mL or ~3.33 mcg/µL), reducing viscosity and facilitating accurate pipetting across automated workstation platforms.

To verify dilutions and convert between microgram targets and micropipette microliter volumes, researchers can utilize the PX1 interactive reconstitution calculator tool before preparing stock solutions on the bench.

Aliquot Strategy and Stability Protocols

Once reconstituted, liquid Sermorelin is significantly more susceptible to enzymatic degradation, thermal cleavage, and surface adsorption than its lyophilized counterpart. To maintain concentration fidelity across multi-week assay schedules, establishing an immediate aliquot strategy upon reconstitution is critical.

Aqueous Sermorelin solutions should be divided into single-use micro-aliquots using low-binding polypropylene microcentrifuge tubes. This step prevents repeated freeze-thaw cycles, which induce shear stress, ice-crystal formation, and peptide denaturing. Reconstituted aliquots stored at -20°C or -80°C remain stable for extended research windows, whereas working vials held at 4°C should be utilized within 14 to 21 days.

To minimize physical denaturing, reconstitution liquid must be directed slowly down the inner glass wall of the vial rather than sprayed directly onto the lyophilized cake. Gentle swirly rotation should be applied until complete dissolution occurs; mechanical agitation or high-speed vortexing must be strictly avoided as hydrophobic air-liquid interfaces promote irreversible peptide aggregation.

Comparative Analysis: GHRH Analogs and Secretagogues

In preclinical growth factor signaling studies, investigators frequently compare Sermorelin against other synthetic growth hormone secretagogues to evaluate relative receptor affinity, biological half-life, and downstream intracellular cAMP signaling responses.

Sermorelin shares structural homologies with long-acting GHRH derivatives like CJC-1295 No DAC, which features amino acid substitutions designed to resist dipeptidyl peptidase-4 (DPP-IV) cleavage. Similarly, researchers studying full-length or lipid-conjugated GHRH analogs often compare Sermorelin performance with Tesamorelin, a 44-amino-acid peptide modified with a hexenoyl moiety to enhance enzymatic stability in vitro. Furthermore, investigators frequently co-evaluate GHRH receptor agonists alongside ghrelin/GHS-R1a receptor agonists such as Ipamorelin to map synergistic somatotroph activation patterns in preclinical model systems.

Understanding these structural and receptor-target differences allows research teams to select the precise peptide candidate required for their specific pathway analysis, whether focusing on acute binding kinetics or sustained physiological signaling.

Quality Control: HPLC, Mass Spectrometry, and COA Verification

At PX1 Research, product purity and lot uniformity are verified using rigorous analytical techniques in an ISO 17025 accredited laboratory setting. Every production batch of Sermorelin undergoes high-performance liquid chromatography (HPLC) and mass spectrometry (MS) verification to ensure chemical identity and purity targets exceeding 98.0%.

Analytical RP-HPLC profiles confirm the absence of truncated sequences, deletion peptides, and side-chain synthesis artifacts. Electrospray ionization mass spectrometry (ESI-MS) confirms the exact molecular weight of Sermorelin (3357.9 Da), matching theoretical structural calculations. Additionally, every lot is subjected to Limulus Amebocyte Lysate (LAL) testing to verify that bacterial endotoxin levels remain strictly below established preclinical safety thresholds (<0.05 EU/mg).

Investigators can independently verify lot-specific testing data by accessing our public PX1 COA Database. Entering the lot number printed on the vial label displays the full analytical report, chromatographic peaks, mass spectra, and endotoxin compliance certification.

Selecting the Optimal Vial Size: 2mg, 5mg, or 10mg

Choosing between different vial mass presentations—such as 2mg, 5mg, or 10mg—depends on experimental design parameters, duration of the study, and total liquid storage limitations.

Smaller vial sizes, such as a 2mg or 5mg format, are ideal for acute short-term assays where reconstituted material will be consumed within a few days. This minimizes storage duration at 4°C and avoids long-term freeze-thaw cycles. Conversely, the 10mg format is optimal for high-throughput screening, multi-plate cell culture runs, or longitudinal animal studies requiring a unified single-lot batch over extended periods.

If a specific mass size like 10mg is temporarily out of stock or held for custom lot production, researchers can order equivalent total mass using multiple standard sizes from our main Sermorelin catalog to ensure uninterrupted research schedules.

Preclinical Receptor Binding and Signaling Pathways

In vitro models demonstrate that Sermorelin selectively binds to the GHRH receptor, a seven-transmembrane domain G-protein coupled receptor (GPCR) localized on pituitary somatotroph cells. Receptor binding stimulates Gs-alpha subunit interaction, triggering membrane-bound adenylate cyclase activity.

This enzymatic activation converts ATP to cyclic adenosine monophosphate (cAMP), initiating downstream activation of Protein Kinase A (PKA). PKA subsequently phosphorylates the cAMP-response element-binding protein (CREB), which migrates to the nucleus to induce transcriptional upregulation of the growth hormone gene. Preclinical rodent models indicate that this natural signaling cascade preserves physiological feedback loops, as somatostatin (SRIF) binding can modulate excessive signaling at the somatotroph level.

Research in cell culture platforms further confirms that Sermorelin exposure induces intracellular calcium ion influx via L-type voltage-gated calcium channels, promoting rapid exocytosis of pre-stored GH vesicles without disrupting basally expressed cellular homeostasis.

Handling and Reagent Integrity in Laboratory Settings

Maintaining peptide stability requires strict adherence to sterile reagent handling standards within a laminar flow cabinet or biosafety cabinet. Reconstitution diluent should be drawn with sterile, non-pyrogenic syringes to prevent trace endotoxin introduction.

Peptides in solution are sensitive to photo-oxidation; working vials should be shielded from light exposure during storage and bench manipulation. If buffer adjustments are required (such as shifting pH to neutral ranges for cell culture work), adjustments must be monitored carefully to prevent rapid precipitation near the peptide's isoelectric point.

Detailed laboratory documentation, including reconstitution date, diluent volume, lot code, and calculated concentration, should be logged directly on vial secondary containment boxes to maintain experimental traceability across multi-investigator projects. For further mechanistic literature and theoretical background, researchers can explore our extended peptide research portal.

Bulk Sourcing and Laboratory Account Logistics

For institutional facilities, university departments, and contract research organizations (CROs) requiring large-scale allocations of Sermorelin 10mg vials, PX1 Research provides dedicated supply chain services. Bulk lot reservation allows laboratories to secure consistent single-lot inventory for multi-year clinical trial modeling or high-volume screening.

All orders ship directly from our state-of-the-art logistics centers located in California and Arizona, featuring same-day shipping for orders placed Monday through Friday prior to cut-off times. Products are packed with cold packs and insulated shipping materials to protect structural integrity during transit.

Principal investigators and laboratory managers seeking custom fill sizes, volume discounts, or custom quality control testing options can establish institutional accounts through our wholesale peptide portal.